We all feel pain. Some 87 million Americans and over 290 million individuals worldwide suffer from some form of chronic pain. Sales of therapeutics for pain management reached over $20 billion last year, up 11%.
To learn more about the past, present and future of the pain management market then don't miss the latest issue of Neurotech Insights - the neurotechnology investment newsletter. Included in this issue:
-Next Generation Pain Treatments (in-depth analysis with latest clinical trials)
-Interview with Pain Therapeutics CEO, Remi Barbier
-Discussion of neurostimulation treatments for pain management
-Market analysis of public companies (RNVS, CEPH, MDT, DOVP, NTII, SHPGY)
-Deals, alliances and financings
-Neurotech Index performance (companies treating neurological diseases)
Address: 5636 Lemon Ave.
Dallas TX 75209
Phone: +1 214 5203694